CED Cannabis Science Digest: Pregnancy Risk Perception Signals
This digest highlights pregnancy safety beliefs cannabis signals from recent studies. It covers U.S. survey data on pregnancy risk perception and cannabis use trends among women of childbearing age. Additionally, it examines cannabis expectancies among…
Prenatal Cannabis Exposure and Neurodevelopment: What the New Systematic Review Actually Shows
A July 4, 2026 systematic review examined prenatal cannabis neurodevelopment impact, finding no consistent global cognitive impairment but more behavioral and attention difficulties. The evidence supports cautious counseling during pregnancy. This review…
Cannabis for PTSD: What 26 Studies and 3,598 Patients Actually Show
A new scoping review of 26 studies and 3,598 patients found that cannabis-based interventions mostly failed to outperform placebo for PTSD. The one exception was narrow: a synthetic cannabinoid that reduced nightmares. Here is what the evidence actually…
CED Cannabis Science Digest: 3 CUD, Dosing, and Neurobiology Signals Worth Watching
This digest presents 2026 cannabis use disorder research focusing on three key signals: cannabis use disorder recovery biology, THC pharmacokinetic variability, and cannabinoid neurobiology. The included studies provide educational insights without…
Cannabis Before Lumbar Fusion: What the Revision-Risk Meta-Analysis Actually Shows
A 2026 meta-analysis found lumbar fusion revision risk cannabis use was linked to higher odds of revision surgery. The evidence is based on five heterogeneous studies and does not prove causation. This calls for careful preoperative counseling and risk…
CED Cannabis Science Digest: Legalization, Mood, and Pain Signals
This digest highlights the Luxembourg cannabis legalization study alongside two preclinical CBD signals on mood and neuropathic pain. These findings are informative but not treatment proof. They help clarify policy monitoring and translational research…
THC/CBD for Restless Legs Syndrome: What a Small Trial Shows
A July 2, 2026 clinical trial found lower restless legs syndrome scores and less wake-after-sleep-onset with a low-dose THC/CBD product. The signal is interesting, but the 18-patient open-label design and MS-heavy cohort leave major caveats. Here is what…
What 102 Systematic Reviews Say About Cannabis for Pain, IBD, and MS
A 2026 overview of 102 systematic reviews maps where cannabinoid evidence is strongest and where it falls short. Key findings for chronic pain, IBD, and multiple sclerosis.
Cannabis Science Evidence Report: Systematic Review and Meta-Analysis
A comprehensive systematic review and meta-analysis has investigated the prevalence of cannabis use and cannabis use disorder in individuals with early-onset psychosis. The study's findings have significant implications for clinicians and patients…
Cannabis Science Digest: 3 Perinatal, Sleep, and Metabolic Signals Worth Watching
This cannabis science digest highlights perinatal cannabis research recruitment alongside sleep and metabolic signals. The perinatal paper improves research infrastructure for studying cannabis use in pregnancy. The sleep and metabolic studies offer…